Ameritas Investment Partners’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $417K | Buy |
12,842
+280
| +2% | +$9.1K | 0.01% | 919 |
|
|
2025
Q1 | $474K | Sell |
12,562
-206
| -2% | -$7.78K | 0.02% | 838 |
|
|
2024
Q4 | $1.05M | Buy |
12,768
+886
| +7% | +$72.5K | 0.03% | 614 |
|
|
2024
Q3 | $1.36M | Buy |
11,882
+1,186
| +11% | +$136K | 0.04% | 517 |
|
|
2024
Q2 | $808K | Buy |
10,696
+151
| +1% | +$11.4K | 0.03% | 672 |
|
|
2024
Q1 | $720K | Buy |
10,545
+1,050
| +11% | +$71.7K | 0.02% | 711 |
|
|
2023
Q4 | $596K | Buy |
9,495
+278
| +3% | +$17.5K | 0.02% | 754 |
|
|
2023
Q3 | $470K | Buy |
9,217
+1,625
| +21% | +$82.8K | 0.02% | 790 |
|
|
2023
Q2 | $379K | Buy |
7,592
+1,853
| +32% | +$92.5K | 0.01% | 849 |
|
|
2023
Q1 | $215K | Hold |
5,739
| – | – | 0.01% | 1050 |
|
|
2022
Q4 | $258K | Buy |
5,739
+1,786
| +45% | +$80.4K | 0.01% | 995 |
|
|
2022
Q3 | $94K | Hold |
3,953
| – | – | ﹤0.01% | 1532 |
|
|
2022
Q2 | $86K | Buy |
3,953
+836
| +27% | +$18.2K | ﹤0.01% | 1617 |
|
|
2022
Q1 | $75K | Hold |
3,117
| – | – | ﹤0.01% | 1816 |
|
|
2021
Q4 | $74K | Hold |
3,117
| – | – | ﹤0.01% | 1873 |
|
|
2021
Q3 | $79K | Hold |
3,117
| – | – | ﹤0.01% | 1839 |
|
|
2021
Q2 | $70K | Buy |
3,117
+761
| +32% | +$17.1K | ﹤0.01% | 1961 |
|
|
2021
Q1 | $47K | Buy |
2,356
+804
| +52% | +$16K | ﹤0.01% | 2123 |
|
|
2020
Q4 | $41K | Hold |
1,552
| – | – | ﹤0.01% | 2094 |
|
|
2020
Q3 | $77K | Buy |
+1,552
| New | +$77K | ﹤0.01% | 1588 |
|